php // dynamic_sidebar( 'budget-banner-widget' );
?>
php // }
?>
-
The index consists of 25 Covid-stocks broadly categorised into five verticals of the healthcare industry — vaccine manufacturers, pharma companies, hospital chains, pathology laboratories and medical equipment manufacturers
-
Investment by mutual funds in equities will continue in coming months seeing the increase in user growths as multiple fintech players are entering into this space, says an industry expert
-
The market valuation of TCS jumped Rs 34,623.12 crore to reach Rs 11,58,542.89 crore. Hindustan Unilever Ltd added Rs 13,897.69 crore to take its valuation to Rs 5,66,950.71 crore
-
Investors seem to have factored in the heightened daily COVID cases and are currently looking beyond the short-term impact, say analysts
-
The metal and pharma sectors are likely to continue their bull run whereas in the short term, BFSI, FMCG and auto sectors are likely to see some short-covering
-
The benchmark equity index BSE Sensex surged 424 points, or 0.87%, to 49,206 during the week.
-
Axis Securities has recommended over 10 stocks that can deliver robust returns to investors in the long run
-
Cipla, Dr Reddy's Laboratories, L&T and Vedanta are scheduled to announce their Q4 results on May 14
-
The focus of RBI has been towards providing assistance to those requiring the most critical assistance
-
Reliance Power's total income stood at Rs 1,691.19 crore in the March quarter compared to Rs 1,902.03 crore a year ago